Table 5.
Comparison of urodynamic parameters between the five subgroups.
| Glom 0/1 MBC ≥ 760 |
Glom 0/1 MBC < 760 |
Glom 2/3 MBC ≥ 760 |
Glom 2/3 MBC < 760 |
Hunner’s lesion |
P | P < 0.05 | |
|---|---|---|---|---|---|---|---|
| Subgroup | 1 | 2 | 3 | 4 | HL | ||
| N | 95 | 107 | 41 | 224 | 19 | ||
| FSF (ml) | 141 ± 54 | 118 ± 47 | 119 ± 57 | 113 ± 49 | 82.4 ± 45 | 0.000 | 1 vs 2, 4, HL |
| FS (ml) | 219 ± 71 | 182 ± 67 | 198 ± 75 | 181 ± 66 | 117 ± 62 | 0.000 | HL vs 1,2,3,4 1 vs 2,4, HL |
| US (ml) | 264 ± 82 | 225 ± 76 | 253 ± 95 | 226 ± 79 | 132 ± 67 | 0.000 | HL vs 1,2,3,4 1 vs 2,4, HL |
| CBC (ml) | 349 ± 129 | 281 ± 112 | 304 ± 120 | 266 ± 113 | 179 ± 109 | 0.000 | HL vs 1,2,3,4 1 vs 2,4, HL |
| Pdet (cmH2O) | 23.1 ± 12.8 | 21.9 ± 14.5 | 21.0 ± 11.7 | 22.6 ± 27.9 | 16.3 ± 11.6 | 0.762 | |
| Qmax (ml/s) | 14.2 ± 6.7 | 11.8 ± 6.5 | 13.6 ± 5.5 | 12.6 ± 10.0 | 9.9 ± 4.3 | 0.102 | |
| Volume (ml) | 322 ± 14 | 241 ± 106 | 298 ± 116 | 232 ± 102 | 129 ± 88 | 0.000 | HL vs 1,2,3,4 1 vs 2,4, HL |
| PVR (ml) | 26.3 ± 51 | 40.4 ± 97.8 | 12.7 ± 21.8 | 33.6 ± 66.1 | 49.3 ± 96.1 | 0.175 | |
| Compliance | 87.6 ± 82 | 70.7 ± 72 | 63.8 ± 66 | 58.8 ± 60 | 34.1 ± 26 | 0.002 | 1 vs 4, HL |
| UDS DV | 9 (9.5%) | 10 (9.3%) | 4 (0.8%) | 18 (8.0%) | 1 (5.3%) | 0.964 | |
| BND | 4 (4.2%) | 6 (5.6%) | 1 (2.4%) | 7 (3.1%) | 0 (0%) | 0.684 | |
| PRES | 40 (42.1%) | 48 (44.9%) | 15 (36.6%) | 111 (49.6%) | 10 (52.6%) | 0.467 | |
| HSB | 68 (71.6%) | 90 (84.1%) | 31 (75.6%) | 210 (93.8%) | 19 (100%) | 0.000 | |
| DO | 11 (11.6%) | 14 (13.1%) | 4 (9.8%) | 24 (10.7%) | 4 (21.1%) | 0.706 |
The data are presented as mean ± standard deviation or number (percentage). Glom, glomerulation grade; MBC, maximal bladder capacity (ml); FSF, first sensation of filling; FS, full sensation; US, urge sensation; CBC, cystometric bladder capacity; Pdet, voiding detrusor pressure; Qmax, maximum flow rate; PVR, post-void residual urine; UDS, urodynamic study; DV, dysfunctional voiding; BND, bladder neck dysfunction; PRES, poor relaxation of external sphincter; HSB, hypersensitive bladder; DO, detrusor overactivity.